129 results

• Study Raises New Questions Over Ozempic Hair Loss Risks

  September 26, 2025

  Irvin Jackson

  Researchers are calling for doctors to warn patients about potential Ozempic and Mounjaro hair loss risks, which may increase with weight loss.

• Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges

  September 24, 2025

  Irvin Jackson

  A lawsuit over Mounjaro side effects claims the diabetes drug led to a bowel obstruction resulting in permanent injuries.

• Ozempic Bowel Obstruction Caused Severe, Permanent Injuries: Lawsuit

  September 19, 2025

  Irvin Jackson

  An Ozempic lawsuit claims a Wisconsin woman suffered small bowel obstruction and gastroparesis after using the popular diabetes and weight loss drug.

• Woman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction

  September 5, 2025

  Irvin Jackson

  A lawsuit against the makers of Ozempic and Trulicity claims the side effects caused a woman's intestines to stop contracting, leading to a dangerous intestinal blockage.

• MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers

  August 29, 2025

  Irvin Jackson

  Eli Lilly seeks to consolidate all GLP-1 vision loss lawsuits into a new MDL, and assign them to the same court where the drugs' gastroparesis injury cases are being held.

• Mounjaro Stomach Paralysis Risks Higher Than Other Diabetes Drugs, Review Finds

  August 26, 2025

  Irvin Jackson

  Chinese researchers have compiled an evolving review of diabetes drug side effects, which links Mounjaro to the highest risk of gastrointestinal problems, including stomach paralysis.

• Gastric Emptying Study Will Be Required in Ozempic Gastroparesis Lawsuits: MDL Order

  August 20, 2025

  Irvin Jackson

  All plaintiffs filing Ozempic gastroparesis lawsuits, or gastroparesis claims involving other GLP-1 drugs, must be diagnosed through a number of court-approved gastric emptying studies.

• Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis

  August 15, 2025

  Irvin Jackson

  The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries.

• GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns

  August 6, 2025

  Irvin Jackson

  New research suggests that vision problems are not restricted to just Ozempic, but may be a risk faced by all GLP-1 medication users.

• Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries

  July 29, 2025

  Irvin Jackson

  A Mounjaro lawsuit claims an Ohio woman suffered severe injuries due to a lack of warnings about the risks of stomach paralysis.